Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
NewAmsterdam Pharma Company N.V. | NAMS | 275K | $9.32M |
Travere Therapeutics, Inc. | TVTX | 300K | $17.04M |
COMPASS Pathways plc | CMPS | 301.18K | $4.26M |
Abivax S.A. | ABVX | 330K | $43.98M |
Teva Pharmaceutical Industries Limited | TEVA | 374K | $12.67M |
Dianthus Therapeutics, Inc. | DNTH | 400K | $38.99M |
IDEAYA Biosciences, Inc. | IDYA | 400K | $14.91M |
Cogent Biosciences, Inc. | COGT | 450K | $17.41M |
Enliven Therapeutics, Inc. | ELVN | 500K | $25.38M |
Cytokinetics, Incorporated | CYTK | 550K | $46.85M |
Oruka Therapeutics, Inc. | ORKA | 590K | $56.15M |
Insmed Incorporated | INSM | 650K | $69.3M |
Celldex Therapeutics, Inc. | CLDX | 700K | $26.05M |
Korro Bio, Inc. | KRRO | 706.9K | $9.32M |
Mineralys Therapeutics, Inc. | MLYS | 750K | $20.23M |
Odyssey Therapeutics, Inc. | ODTX | 766.35K | $14.34M |
AnaptysBio, Inc. | ANAB | 826.11K | $55.76M |
Jade Biosciences, Inc. | JBIO | 840.35K | $18.67M |
Cullinan Therapeutics, Inc. | CGEM | 875.76K | $15.95M |
Nurix Therapeutics, Inc. | NRIX | 967.62K | $23.47M |